News
AquaBounty Technologies Engages MZ Group to Lead Investor Relations and Shareholder Communication Program
MAYNARD, Mass., May 12, 2020 (GLOBE NEWSWIRE) — AquaBounty Technologies, Inc. (NASDAQ: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance…
Share
Phathom Pharmaceuticals Reports First Quarter 2020 Results
FLORHAM PARK, N.J., May 12, 2020 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing…
Share
Seelos Therapeutics to Participate in the Jefferies Virtual Healthcare Conference
NEW YORK, May 12, 2020 (GLOBE NEWSWIRE) — Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous…
Share
Arbutus to Present at UBS Virtual Global Healthcare Conference
WARMINSTER, Pa., May 12, 2020 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company focused on developing a cure for people with…
Share
Catalyst Pharmaceuticals Announces First Quarter 2020 Financial Results and Provides Corporate Update
Firdapse® Q1 2020 Net Revenues of $29.1 MillionFirst Quarter 2020 GAAP Net Income of $10.4 MillionCatalyst Withdraws Previous 2020 Revenue Guidance Due to COVID-19 UncertaintiesCatalyst to…
Share
Novavax Reports First Quarter 2020 Financial Results
CEPI increases investment up to $388 million for NVX‑CoV2373 vaccine development & manufacturingNVX‑CoV2373 Phase I trial initiating in May with preliminary results in JulyNanoFlu…
Share
Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing
Funds clinical development of NVX-CoV2373 through Phase 2Supports rapid scale-up of vaccine manufacturingAllows for increased production of Matrix-M adjuvantReserves global large-scale…
Share
Liquidia Reports First Quarter 2020 Financial Results and Provides Corporate Update
Received FDA Acceptance of LIQ861 NDA for ReviewReported Final Safety and Tolerability Results for LIQ861 Inspire TrialManagement to Host Webcast and Conference Call Today at 4:30p.m…
Share
Novavax to Present COVID-19 Vaccine Candidate Progress in World Vaccine Congress Webinar Series
GAITHERSBURG, Md., May 11, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases…
Share
Onconova Therapeutics Announces Virtual Format for 2020 Annual Meeting of Stockholders
NEWTOWN, Pa., May 11, 2020 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to…
Share